Detalles de la búsqueda
1.
[The effectiveness of tele-rehabilitation for patients with multiple sclerosis during the COVID-19 pandemic in 2020-2021 was evaluated in this study]. / Effektivnost' telereabilitatsii patsientov s rasseyannym sklerozom v usloviyakh pandemii koronavirusnoi infektsii v 20202021 gg.
Zh Nevrol Psikhiatr Im S S Korsakova
; 124(3): 75-81, 2024.
Artículo
en Ruso
| MEDLINE | ID: mdl-38529866
2.
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]. / Effektivnost' i bezopasnost' dvukhletnei terapii divozilimabom u patsientov s rasseyannym sklerozom v ramkakh randomizirovannogo dvoinogo slepogo platsebo-kontroliruemogo klinicheskogo issledovaniya BCD-132-4/MIRANTIBUS.
Zh Nevrol Psikhiatr Im S S Korsakova
; 124(4): 86-96, 2024.
Artículo
en Ruso
| MEDLINE | ID: mdl-38676683
3.
[Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population]. / Otsenka effektivnosti i bezopasnosti alemtuzumaba u patsientov s vysokoaktivnym techeniem rasseyannogo skleroza v rossiiskoi populyatsii.
Zh Nevrol Psikhiatr Im S S Korsakova
; 123(9): 76-82, 2023.
Artículo
en Ruso
| MEDLINE | ID: mdl-37796071
4.
[Long-term Efficacy and Safety of Sampeginterferon-ß1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results]. / Dolgosrochnye dannye po effektivnosti i bezopasnosti preparata sampeginterferon-ß1a u patsientov s remittiruyushchim rasseyannym sklerozom: rezul'taty 104-nedel'nogo randomizirovannogo dvoinogo slepogo klinicheskogo issledovaniya.
Zh Nevrol Psikhiatr Im S S Korsakova
; 123(2): 52-59, 2023.
Artículo
en Ruso
| MEDLINE | ID: mdl-36843459
5.
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]. / Effektivnost' i bezopasnost' 48 nedel'nogo primeneniya monoklonal'nogo antitela protiv CD20 divozilimaba u patsientov s rasseyannym sklerozom: rezul'taty randomizirovannogo dvoinogo slepogo platsebo-kontroliruemogo klinicheskogo issledovaniya BCD-132-4/MIRANTIBUS.
Zh Nevrol Psikhiatr Im S S Korsakova
; 123(7. Vyp. 2): 43-52, 2023.
Artículo
en Ruso
| MEDLINE | ID: mdl-37560833
6.
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. / Effektivnost' i bezopasnost' 24 nedel' primeneniya divozilimaba sredi patsientov s rasseyannym sklerozom v ramkakh randomizirovannogo dvoinogo slepogo platsebo-kontroliruemogo klinicheskogo issledovaniya BCD-132-2.
Zh Nevrol Psikhiatr Im S S Korsakova
; 123(4): 37-47, 2023.
Artículo
en Ruso
| MEDLINE | ID: mdl-37084363
7.
Vaccination and Multiple Sclerosis - Current Situation.
Neurosci Behav Physiol
; 52(4): 486-490, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35875700
8.
[Dance therapy in the rehabilitation of neurological diseases]. / Tantseval'no-dvigatel'naya terapiya v reabilitatsii nevrologicheskikh zabolevanii.
Zh Nevrol Psikhiatr Im S S Korsakova
; 122(7. Vyp. 2): 31-35, 2022.
Artículo
en Ruso
| MEDLINE | ID: mdl-35912554
9.
[Long-term treatment for multiple sclerosis with interferon beta-1b. Outcomes of an open, retrospective, observational study]. / Dolgosrochnaya terapiya rasseyannogo skleroza interferonom beta-1b. Rezul'taty retrospektivnogo otkrytogo nablyudatel'nogo issledovaniya.
Zh Nevrol Psikhiatr Im S S Korsakova
; 122(7. Vyp. 2): 96-103, 2022.
Artículo
en Ruso
| MEDLINE | ID: mdl-35912564
10.
[New opportunities in the treatment of patients with multiple sclerosis (Resolution of the Council of Experts on April 23, 2022, Moscow, JSC «BIOCAD¼)]. / Novye vozmozhnosti v terapii patsientov s rasseyannym sklerozom¼ (Rezolyutsiya soveta ekspertov 23 aprelya 2022 goda, Moskva, AO «BIOKAD¼).
Zh Nevrol Psikhiatr Im S S Korsakova
; 122(7. Vyp. 2): 84-88, 2022.
Artículo
en Ruso
| MEDLINE | ID: mdl-35912562
11.
[Possibilities of art therapy and color therapy in the rehabilitation of multiple sclerosis]. / Vozmozhnosti art-terapii i tsvetoterapii v reabilitatsii pri rasseyannom skleroze.
Zh Nevrol Psikhiatr Im S S Korsakova
; 121(7. Vyp. 2): 49-55, 2021.
Artículo
en Ruso
| MEDLINE | ID: mdl-34387446
12.
[Preliminary results of rehabilitation intervention for the correction of cognitive impairment in patients with multiple sclerosis]. / Predvaritel'nye rezul'taty reabilitatsionnoi interventsii dlya korrektsii kognitivnykh narushenii u bol'nykh rasseyannym sklerozom.
Zh Nevrol Psikhiatr Im S S Korsakova
; 121(7. Vyp. 2): 94-98, 2021.
Artículo
en Ruso
| MEDLINE | ID: mdl-34387454
13.
[Vaccination and multiple sclerosis at the present stage]. / Vaktsinatsiya i rasseyannyi skleroz na sovremennom etape.
Zh Nevrol Psikhiatr Im S S Korsakova
; 121(7. Vyp. 2): 44-48, 2021.
Artículo
en Ruso
| MEDLINE | ID: mdl-34387445
14.
The Novel Coronavirus Infection (COVID-19) and Nervous System Involvement: Mechanisms of Neurological Disorders, Clinical Manifestations, and the Organization of Neurological Care.
Neurosci Behav Physiol
; 51(2): 147-154, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33619413
15.
[The use of music therapy in the treatment of adverse effects in patients with multiple sclerosis treated with alemtuzumab]. / Primenenie muzykal'noi terapii dlya korrektsii nezhelatel'nykh yavlenii pri terapii alemtuzumabom u bol'nykh rasseyannym sklerozom.
Zh Nevrol Psikhiatr Im S S Korsakova
; 120(7. Vyp. 2): 73-76, 2020.
Artículo
en Ruso
| MEDLINE | ID: mdl-32844634
16.
[Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care]. / Novaya koronavirusnaya infektsiya (COVID-19) i porazhenie nervnoi sistemy: mekhanizmy nevrologicheskikh rasstroistv, klinicheskie proyavleniya, organizatsiya nevrologicheskoi pomoshchi.
Zh Nevrol Psikhiatr Im S S Korsakova
; 120(6): 7-16, 2020.
Artículo
en Ruso
| MEDLINE | ID: mdl-32678542
17.
[New directions of immunocorrection in multiple sclerosis]. / Novye napravleniia immunokorrektsii pri rasseiannom skleroze.
Zh Nevrol Psikhiatr Im S S Korsakova
; 120(2): 103-109, 2020.
Artículo
en Ruso
| MEDLINE | ID: mdl-32307419
18.
[Updated recommendations of the Council of Experts on the use and safety of alemtuzumab (Lemtrada)]. / Obnovlennye rekomendatsii soveta ekspertov po primeneniyu i obespecheniyu bezopasnosti terapii preparatom alemtuzumab (Lemtrada).
Zh Nevrol Psikhiatr Im S S Korsakova
; 120(3): 82-91, 2020.
Artículo
en Ruso
| MEDLINE | ID: mdl-32323949
19.
[Clinical cases of multiple sclerosis in children with cerebral palsy]. / Klinicheskie sluchai rasseiannogo skleroza u detei s detskim tserebral'nym paralichom.
Zh Nevrol Psikhiatr Im S S Korsakova
; 118(8. Vyp. 2): 55-61, 2018.
Artículo
en Ruso
| MEDLINE | ID: mdl-30160669
20.
[The risk of ischemic stroke in patients with multiple sclerosis]. / Risk razvitiia ishemicheskogo insul'ta u bol'nykh rasseiannym sklerozom.
Zh Nevrol Psikhiatr Im S S Korsakova
; 118(8. Vyp. 2): 88-94, 2018.
Artículo
en Ruso
| MEDLINE | ID: mdl-30160674